US20010020172A1 - Catheter system for treating a vascular occlusion - Google Patents
Catheter system for treating a vascular occlusion Download PDFInfo
- Publication number
- US20010020172A1 US20010020172A1 US09/032,773 US3277398A US2001020172A1 US 20010020172 A1 US20010020172 A1 US 20010020172A1 US 3277398 A US3277398 A US 3277398A US 2001020172 A1 US2001020172 A1 US 2001020172A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- assembly
- set forth
- occlusion
- blunt end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2215—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having an open distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320044—Blunt dissectors
Definitions
- This invention relates generally to medical devices and especially intravascular catheters designed to operate with respect to occlusions within a blood vessel. More particularly, this invention relates to intravascular catheters having the ability to fracture an occlusion sufficiently for allowing a guide wire to pass through the occlusion within the natural lumen of the blood vessel.
- An occlusion may be partial or total, may be soft and pliable or hard and calcified, and may be found at a great variety of sites in the arterial system including the aorta, the coronary and carotid arteries, and peripheral arteries.
- coronary artery occlusions have been treated by performing coronary bypass surgery, in which a segment of the patient's saphenous vein is taken from the patient's leg and is grafted onto the affected artery at points proximal (upstream) and distal (downstream) to the occluded segment.
- the bypass often provides dramatic relief.
- it entails dangerous open chest surgery and a long, painful, costly convalescence in the hospital.
- the bypass patient's saphenous vein graft can also become occluded.
- a second bypass procedure may be performed, once again entailing open chest surgery and prolonged hospitalization. Thereafter, if the underlying atherosclerotic disease process is not controlled, the prognosis is dismal.
- PTCA percutaneous transluminal coronary angioplasty
- DCA directional coronary atherectomy
- PTCA employs a balloon to mechanically dilate the stenosis.
- a steerable guidewire is introduced and advanced under fluoroscopic observation into the stenosed artery and past the stenosis.
- a balloon-tipped catheter is advanced over the guidewire until it is positioned across the stenosed segment.
- the balloon is then inflated, separating or fracturing the atheroma (stenosed tissue).
- the hoped-for outcome is that, over time, the lumen will stay open.
- a catheter containing a cutter housed in its distal end is advanced over the guidewire into the stenosed segment.
- the housing is urged against the atheroma by the inflation of a balloon, so that part of the atheroma intrudes through a window in the side of the housing.
- the cutter is used to shave away the atheroma. The shavings are collected in the nosecone of the housing and withdrawn along with the catheter.
- Stenting is a procedure in which a wire framework, known as a stent, is compressed and delivered a balloon catheter.
- the stent is positioned across the stenosed segment of the artery.
- the balloon is inflated, dilating the stent and forcing the stent against the artery wall.
- the hoped-for outcome is that the stent will hold the arterial lumen open for a prolonged period.
- a stent is placed in an artery immediately following PTCA or DCA.
- the aforementioned catheters are “over-the-wire catheters”. These catheters depend on the guidewire, which typically has a tiny bent portion at its distal end for steering. Over-the-wire catheters cannot be positioned adjacent the stenosis until the guidewire has been advanced across the stenosed arterial segment. Thus, where the occlusion is too severe to be crossed by a guidewire or where there is not enough room for the balloon, cutter, or stent delivery catheter, neither PTCA nor DCA nor stenting can be done. Unfortunately, the occlusion often contains extremely hard, calcified tissue and presents an impenetrable barrier to the guidewire.
- a less than total occlusion may contain complex structures which divert or trap the steering end of the guidewire.
- the guidewire might not completely cross the occlusion, but become diverted into the subintimal space between the intima and the atheroma or become buried in the atheroma. In either case, the guidewire cannot be positioned across the stenosis to guide a balloon or cutting element. In such cases, bypass surgery may be necessary with the associated cost, risks, and recovery period.
- Biplane fluoroscopy One guidance system which has been used in conjunction with coronary catheterization is biplane fluoroscopy, wherein the interventionist observes two flat real-time x-ray images acquired from different angles.
- Biplane fluoroscopy is unreliable, costly, and slow. Delay is unacceptable, for it contributes to trauma and stress and creates opportunities for complications and failures of technique.
- OCT Optical Coherence Tomography
- a beam of light carried by an optical fiber illuminates the artery interior.
- light reflected back into the fiber from features inside the artery is correlated with the emitted light to capture the depth as well as the angular separation of those features.
- the features are displayed graphically in two or three dimensions through the use of a suitably programmed computer.
- the beam in OCT is swept by mechanical rotation or movement of optical components in the catheter, or by optical switching devices which select one of several fibers through which to perform measurements.
- the rotation is encoded, or the switching pattern recorded, for reconstructing angular information about the artery interior.
- a beam splitter may be placed between the light source and the catheter fiber to produce a reference beam which is directed to a reflector at a known distance.
- the catheter beam and the reference beam are recombined as they return.
- interference fringes are observable in the combined beam. Since the lengths of the reference path and the catheter fiber are known, the distance from the fiber end to a particular reflective feature within the artery can be inferred.
- signals may also be impressed upon the light beam to facilitate the measurement of distance or the detection of motion of objects relative to the fiber end.
- the assembly includes a catheter having a distal end and a proximal end and wherein a working end member fits in an interchangeable manner to the distal end of the catheter and wherein the working end comprises a blunt end member in accordance with the invention.
- blunt end member has a first closed position and a second open position and may be repeatedly opened and closed for fracturing the occlusion within the native lumen of the blood vessel.
- the blunt end member assembly in accordance with this invention comprises:
- a blunt end member connectable to the distal end of the catheter, the blunt end member sized and shaped for fitting within the blood vessel and for fracturing the occlusion, the blunt end member having a first position for allowing the blunt end member to be located at the occlusion and a second position for fracturing the occlusion;
- an actuation member for moving the blunt end member between the first and second positions
- blunt end member is connectable to the distal end of the catheter and the blunt end member is deliverable to the occlusion in the first position and is actuable to a second position for fracturing the occlusion.
- an over-the-wire intravascular catheter comprising a blunt end member disposed at the distal end thereof and a securing balloon disposed about the distal end zone of the catheter proximal to the blunt end member.
- the catheter and blunt end member are sized and shaped so as to allow the blunt end member to be advanced into contact with an occlusion in an artery.
- the balloon is disposed on the outer surface of the distal end zone of the catheter and is inflatable to secure the distal end of the catheter within the artery and thus to maintain engagement of the blunt end member with the occlusion.
- a balloon inflation lumen is provided in the catheter.
- the blunt end member comprises four jaw sections flexibly attached to the distal end of the catheter and arranged symmetrically about the longitudinal axis thereof.
- the catheter comprises a retractable actuation shad having a ball-shaped ferrule fixed to the distal end thereof between the jaw sections.
- the actuation shad includes a lumen and the ferrule includes a center opening.
- the jaw sections have a first, closed position in which the catheter may be advanced to engage the jaws with the occlusion. When the actuation shaft, is retracted, the ferrule impinges upon the inner surfaces of the jaw sections, urging them apart toward a second, open position to fracture the occlusion.
- fracturing force is stably applicable to a severe or total arterial occlusion. It is a further advantage of this exemplary embodiment that a mechanical working element is stably operable upon a severe or total arterial occlusion in a manner unlikely to perforate the adventitia.
- the jaw sections are spade-shaped. In the first, closed position, the jaw sections form a channel substantially confining the guidewire to the longitudinal axis of the blunt end member. It is an advantage of this exemplary embodiment that when the jaw sections are in the first, closed position, a guidewire may be advanced into a portion of the occlusion bounded by the points of contact with the distal ends of the jaw sections.
- the ferrule has a frusto-conical profile.
- each jaw section includes a rectangular distal end.
- the actuation member includes an actuation cable disposed in the catheter.
- the proximal end of the cable is manipulable from the proximal end of the catheter and the distal end of the cable is attached to the ferrule. It is an advantage of this exemplary embodiment of the invention that the cable increases the tension capacity of the actuation member during retraction of the ferrule.
- the jaw sections are fabricated from an alloy comprising Nickel and Titanium. It is an advantage of this exemplary embodiment of the invention that the superelastic properties of the alloy facilitate spreading of the jaw sections when the ferrule is retracted.
- a part of the lumen of the actuating member includes a friction reducing coating. It is an advantage of this exemplary embodiment of the invention that the catheter and blunt end slide easily over the guidewire.
- the mating surface defined by the impingement of the actuation member upon the blunt end member includes a friction reducing coating. It is an advantage of this exemplary embodiment of the invention that the actuation member encounters minimal frictional resistance while urging the jaw sections apart.
- the entire blunt end member is fabricated from a single piece of material. It is an advantage of this exemplary embodiment of the invention that fabrication of the blunt end member does not require attachment or assembly of multiple parts.
- the blunt end member includes a rigid tubular reinforcing member slidably disposed about the actuation shaft inside the distal end zone of the catheter.
- a tubular support member is disposed on the outer surface of the distal end of the catheter.
- the distal end of the support member includes a spring member deformably supporting a plurality of jaw sections. The support member is crimped onto the distal end zone of the catheter, securing the catheter onto the reinforcing member. It is an advantage of this exemplary embodiment of the invention that a simple yet secure attachment is formed between the catheter and the blunt end member.
- FIG. 1 illustrates an exemplary embodiment of the blunt end member for fracturing a total occlusion in accordance with this invention shown in partial cross section.
- FIG. 2 is a partial cross sectional view of the catheter having the blunt end member of FIG. 1 in the process of fracturing the total occlusion.
- FIG. 3 is an enlarged side view of the blunt end member having a first closed position and a second open position.
- FIG. 4 is an end view of the blunt end member of FIG. 3 in the first or closed position.
- FIG. 5 is a cross sectional plane view of the blunt end member of FIG. 1 shown in cross sectional view.
- FIG. 6 is a cross sectional view of the blunt end member of FIG. 1 shown in the second open position.
- FIG. 7 is a cross sectional plane view of another exemplary embodiment of the blunt end member in accordance with this invention.
- FIG. 8 is a cross sectional view of the blunt end member of FIG. 7 shown in the second open position.
- FIG. 9 is an end view of the blunt end member of FIG. 8.
- FIG. 10 is an enlarged end view of the blunt end member of FIG. 7 shown in the second or open position.
- the blunt end member in accordance with this invention, is shown adjacent to a total occlusion where a bypass is in the process of failing.
- the bypass has developed diffuse stenosis as shown in FIGS. 1 and 2. Consistent with the above description, it is quite likely that where stenosis has developed sufficiently to block an arterial blood vessel, after a bypass is performed. stenosis in the bypass will also accumulate. Even, to the point that the bypass may also be blocked or become totally occluded.
- the blunt end member in accordance with this invention, the original, native blood vessel is reopened allowing the bypass to fade as the primary source of blood flow.
- the blunt end member assembly in accordance with this invention, generally designated by the numeral 20 .
- the assembly 20 includes a blunt end member, generally indicated by the numeral 22 , and a catheter 24 .
- An actuation member indicated by doted lines 26 moves the blunt end member from a first closed position as illustrated in FIG. 1 to an second open position as illustrated in FIG. 2.
- the catheter is positioned using a guide wire 28 as best shown in FIG. 2, so that the extreme distal end of the blunt end member is adjacent to the total occlusion, as shown in FIGS. 1 and 2.
- the catheter which includes, in a exemplary embodiment, a member for stabilizing the assembly 20 in the blood, namely, a balloon member 30 .
- the balloon member 30 is inflated as shown in FIG. 2, so that the catheter remains in place during actuation of the blunt end member 22 .
- the blunt end member 22 has a proximal end 40 attached to the distal end of the catheter 24 .
- the method of attachment is conventional within the skill and knowledge of the prior art and is not explained herein in detail.
- the blunt end member includes a set of sectional members defining jaw sections 42 .
- the jaw sections 42 are located at the distal end of the blunt end member and are spaced equal distance of the longitudinal center line 44 .
- the jaw sections 42 open to a second position shown particularly in FIGS. 3 and 6, and close to a first position as shown in FIGS. 3, 4, and 5 .
- an actuation member is required to move the jaw sections 42 from its first closed position to its second open position.
- the jaw sections 42 are generally spade shaped and are separate from one another as illustrated. This allows the jaw sections to meet flush against the arterial wall and the occlusion for optimizing fracturing of the occlusion.
- the jaw sections 42 are spaced apart as shown in FIG. 4.
- FIGS. 5 and 6 there is shown an assembly view of the blunt end member 22 in accordance with the invention as illustrated in FIG. 4.
- FIG. 5 is a cross sectional view along line 5 - 5 of FIG. 4 and looking in the direction of the arrows.
- the blunt end member 22 includes a reverse conical urging member 50 and a spaced apart support member 52 .
- the members 50 and 52 are sized and shaped to fit within the same cavity or lumen of the catheter 24 .
- Each of the members 50 and 52 includes a center opening along the longitudinal center line 44 .
- the openings 50 and 52 are aligned so that a guide wire tube 54 is able to slide toward and away from the proximal end of the catheter 24 .
- the ferrule 56 Attached to the guide wire tube 54 is a ferrule 56 .
- the ferrule 56 also has a center opening aligned with the center openings of the members of 50 and 52 . However, the center opening of the ferrule 56 has a smaller diameter to match the guide wire 28 and not the guide wire tube 54 . Thus, the ferrule 56 is designed to accommodate only the guide wire 28 and not the guide wire tube 54 .
- the guide wire 28 is shown inserted in the center opening of the ferrule 56 . It will also be appreciated that the jaw sections 42 are spaced apart a sufficient distance along the longitudinal center line 44 so that the guide wire is guided thereby. As clearly shown in FIG. 5, the jaw sections 42 , when closed, form a internal guide 58 for sliding the guide wire toward and away from the distal end of the catheter 24 .
- the ferrule 56 may be made from a variety of materials including stainless steel, nickel titanium or other shape memory alloys and various engineering plastics. Additionally, other polymers or metal materials, which are bio-compatible and have the mechanical characteristics necessary to perform the functions herein are equally suitable.
- the ferrule defines a frusto-conical shape, while the urging member 50 forms a reverse compatible shape for sliding against the frusto conical shape of the ferrule 56 .
- the surfaces where each of the ferrule 56 and the urging member 50 contact, define a mating surface.
- the materials selected for each of the ferrule 56 and urging member 50 are compatible for such mating sliding contact.
- the ferrule 56 In response to actuation, the ferrule 56 is pulled toward the proximal end of the catheter 24 causing the ferrule 56 to slide against the urging member 50 , the mating surfaces of each sliding across one another. As the ferrule is pulled towards the proximal end of the catheter, an increasing force is urged against the jaw sections 42 for spreading apart said jaw sections 42 . Upon full activation of the actuation member the jaws are fully open, as shown in FIG. 6.
- the blunt end jaw members 42 must be made of material having sufficient strength to withstand the mechanical forces necessary to fracture the occlusion shown in FIGS. 1 and 2.
- the jaw sections are made from nickel titanium which has proven bio-compatible as well as having sufficient strength for the function intended herein.
- the guide wire tube 54 is bonded to the ferrule as shown in FIGS. 5 and 6.
- the bonding may be similar to the bonding of the catheter and the blunt end member 22 . Additionally, bonding may be done by use of adhesives such as loc-titeTM, soldering, or chemical or physical bonding, of a suitable kind.
- the guide wire tube 54 being thus, permanently connected to the ferrule in a bond which is strong enough to withstand the urging forces exerted against the occlusion.
- the interior opening of the members 50 and 52 provides a guide for the guide wire tube 54 as the jaw sections 42 are opened and closed in repeated use.
- the guide wire tube 54 is a braided strand, and thus can be quite abrasive to the internal opening of the members of 50 and 52 .
- the matter of applying a coating may be increasingly important to reduce the friction in the sliding movement.
- the mating surfaces of the urging member 50 and the ferrule 56 also be as smooth as possible and chosen from compatible materials to minimize the amount of friction developed as the mating surfaces slide against one another in an effort to fracture the occlusion of FIGS. 1 and 2.
- the ferrule and urging members are both made from nickel titanium.
- the urging member 50 is made from stainless steel and the ferrule 56 is made from nickel titanium. Again, the mating surfaces of the ferrule 56 and urging member 50 are made as smooth as possible to minimize the friction there between.
- the support member 52 provides support both internal and external to the assembly 20 .
- the support member 52 remains fixedly attached to the distal end of the catheter 24 and provides an internal opening for the sliding movement of the guide wire tube 54 .
- the jaw sections 42 have a proximal end zone 60 which surrounds both the urging member 50 and the support member 52 .
- the proximal end zone of the jaw sections 42 secures the members 50 and 52 together to provide the assembly 20 .
- the support member is notched at shoulder 62 to provide a secure connection fit with the jaw sections 42 .
- the entire assembly including members 50 and 52 , as well as jaw sections 42 , may be made from a single piece of nickel titanium (NiTi) for a unified assembly.
- the jaw sections would be notched with an opening at elbow 64 , as shown in FIG. 6. This would allow space for deformation of the jaw sections along an axis predetermined by the angle and length of the opening.
- FIGS. 7 through 10 there is shown a second embodiment of the blunt end member in accordance with this invention, generally designated by the numeral 100 .
- the blunt end member 100 includes jaw sections, as illustrated in FIGS. 8 and 10, designated by the numeral 102 .
- the blunt end member 100 includes a spring member 104 and a support member 106 .
- a reinforcing member 108 is positioned between the catheter tube 24 and the guide wire tube 54 in the guide wire lumen of the catheter tube 24 . Attached to the guide wire tube 54 is a ferrule 56 as discussed previously with regard to the earlier described embodiment.
- the spring member 104 has a mating surface for mating with the ferrule 56 , as clearly shown in FIG. 8. Upon actuation, the ferrule 56 is pulled toward the proximal end of the catheter 24 and the mating surfaces engage and separate the jaw sections 102 , as shown in FIGS. 8 and 10. Upon releasing the actuation member, the spring member 104 urges the jaw sections 102 , back to their original and first closed positioned, as clearly shown in FIGS. 7 and 9. The spring member 104 serves to connect the jaw sections 102 and the rest of the blunt end member 100 , and specifically the support member 106 . The support member 106 is crimped at its proximal end 110 .
- the reinforcing member 108 is positioned so that the crimp in the support member 106 sandwiches the distal end of the catheter tube 24 . It will be appreciated that the hoop strength provided by the reinforcing member 108 enables a secure attachment of the support member to the distal end of the catheter tube 24 . It will be further appreciated that the crimp in the support member, plus the added hoop strength provided by the reinforcing member 108 , provide a secure connection for the entire blunt end member 100 .
- the blunt end member is supported by the connections at the joining of the spring 104 , the jaw sections 102 , and support member 106 .
- These joints can be done in a variety of ways. For example, it is preferable to bond the members with an epoxy, should they be made of a polymer or to use welding, soldering, or brazing, if the members are made from metal.
- the spring 104 is made from nickel titanium as are the support member 106 and jaw sections 102 .
- the reinforcing member 108 may be made alternately from nickel titanium or stainless steel. It is also contemplated that various other types of materials are suitable for manufacturing of the blunt end member 100 as described above.
- the blunt end member 100 is in its normal or first closed position, as clearly illustrated in FIG. 7.
- the guide wire 28 is fed through the lumen of the blood vessels of a patient.
- the guide wire will meet an occlusion.
- the blunt end member 100 with ferrule 56 will be positioned, as described earlier, directly adjacent to the occlusion.
- the balloon 30 of FIGS. 1 and 2 may also be adapted for use with the second exemplary embodiment shown in FIGS. 7 through 10.
- the blunt end member 100 is activated by pulling on an actuation member such that the mating surfaces of the spring 104 and the ferrule 56 are brought into contact with one another.
- the ferrule 56 moves the jaw sections 102 away from the longitudinal center line 44 of the catheter as described earlier with reference to FIGS. 1 through 6. This operation is repeated until fracturing occurs, as clearly shown in FIG. 2.
- the catheter may be removed and another working end may be brought to bear upon the occlusion.
- Such working end may include an angioplasty device, atherectomy catheter device, or a stent or other known medical methods, for removing the occlusion once the guide wire 28 is across the occlusion.
Abstract
Description
- 1. Field of the Invention
- This invention relates generally to medical devices and especially intravascular catheters designed to operate with respect to occlusions within a blood vessel. More particularly, this invention relates to intravascular catheters having the ability to fracture an occlusion sufficiently for allowing a guide wire to pass through the occlusion within the natural lumen of the blood vessel.
- 2. Background
- Medical science has long sought effective treatments for disease conditions involving stenosis (narrowing or obstruction) of the lumen (interior passage of the artery) of an artery. This condition, known generally as an occlusion, is found in patients suffering from atherosclerosis (accumulation of fibrous, fatty or calcified tissue in the arteries). An occlusion can manifest itself in hypertension (high blood pressure), ischemia (deficiency of circulation), angina (chest pain), myocardial infarction (heart attack). stroke, or death. An occlusion may be partial or total, may be soft and pliable or hard and calcified, and may be found at a great variety of sites in the arterial system including the aorta, the coronary and carotid arteries, and peripheral arteries.
- Of particular interest to cardiac medicine are the often disabling or fatal occlusions occurring in the coronary arteries (arteries supplying the heart). Traditionally, coronary artery occlusions have been treated by performing coronary bypass surgery, in which a segment of the patient's saphenous vein is taken from the patient's leg and is grafted onto the affected artery at points proximal (upstream) and distal (downstream) to the occluded segment. The bypass often provides dramatic relief. However, it entails dangerous open chest surgery and a long, painful, costly convalescence in the hospital. Moreover, with the passage of time, the bypass patient's saphenous vein graft can also become occluded. If the patient has another saphenous vein, a second bypass procedure may be performed, once again entailing open chest surgery and prolonged hospitalization. Thereafter, if the underlying atherosclerotic disease process is not controlled, the prognosis is dismal.
- Newer, minimally invasive procedures are now preferred in the treatment of arterial occlusions. These procedures use a catheter, a long, thin, highly flexible device which is introduced into a major artery through a small arterial puncture made in the groin, upper arm, or neck and is advanced and steered into the site of the stenosis. At the distal end of the catheter, a great variety of miniature devices have been developed for operating upon the stenosed artery.
- The more popular minimally invasive procedures include percutaneous transluminal coronary angioplasty (PTCA), directional coronary atherectomy (DCA), and stenting. PTCA employs a balloon to mechanically dilate the stenosis. In PTCA, a steerable guidewire is introduced and advanced under fluoroscopic observation into the stenosed artery and past the stenosis. Next, a balloon-tipped catheter is advanced over the guidewire until it is positioned across the stenosed segment. The balloon is then inflated, separating or fracturing the atheroma (stenosed tissue). The hoped-for outcome is that, over time, the lumen will stay open.
- In directional coronary atherectomy, a catheter containing a cutter housed in its distal end is advanced over the guidewire into the stenosed segment. The housing is urged against the atheroma by the inflation of a balloon, so that part of the atheroma intrudes through a window in the side of the housing. Under fluoroscopic observation, the cutter is used to shave away the atheroma. The shavings are collected in the nosecone of the housing and withdrawn along with the catheter.
- Stenting is a procedure in which a wire framework, known as a stent, is compressed and delivered a balloon catheter. The stent is positioned across the stenosed segment of the artery. The balloon is inflated, dilating the stent and forcing the stent against the artery wall. The hoped-for outcome is that the stent will hold the arterial lumen open for a prolonged period. Frequently, a stent is placed in an artery immediately following PTCA or DCA.
- It must be noted, however, that the aforementioned catheters are “over-the-wire catheters”. These catheters depend on the guidewire, which typically has a tiny bent portion at its distal end for steering. Over-the-wire catheters cannot be positioned adjacent the stenosis until the guidewire has been advanced across the stenosed arterial segment. Thus, where the occlusion is too severe to be crossed by a guidewire or where there is not enough room for the balloon, cutter, or stent delivery catheter, neither PTCA nor DCA nor stenting can be done. Unfortunately, the occlusion often contains extremely hard, calcified tissue and presents an impenetrable barrier to the guidewire. Even a less than total occlusion may contain complex structures which divert or trap the steering end of the guidewire. Thus, the guidewire might not completely cross the occlusion, but become diverted into the subintimal space between the intima and the atheroma or become buried in the atheroma. In either case, the guidewire cannot be positioned across the stenosis to guide a balloon or cutting element. In such cases, bypass surgery may be necessary with the associated cost, risks, and recovery period.
- Thus, in patients suffering from severe or total arterial occlusion, it is preferable to do what has been difficult or impossible in the past: to open the severely or totally occluded artery itself, rather than by performing a bypass. If a guidewire and working catheter can be passed through or around the atheroma, the severe or total occlusion can be treated by PTCA, DCA, stenting, site-specific drug delivery or a combination of these proven therapies.
- It would be advantageous to find and open a path of low resistance, either through or around the atheroma. Of course, this must be done without perforating arterial wall. Clearly, the serious consequences of penetrating the arterial wall must be avoided at all costs. The physician will not use a system which would be unsafe and no patient would want a physician to use such a system. Therefore, any solution to the problem of finding and creating an opening through or around the atheroma must be safe and in many instances include a system of guidance for the device that would find and open such an occlusion.
- There has been a long felt need to provide a reliable system of guidance for such a device. As understood by those in the art, the device must travel a criss-crossing, often maze-like structure before it even gets to the occlusion. Then the occlusion itself is often a maze like structure. Attempting to cross such an occlusion without reliable guidance is dangerous. For example, it is easy to dissect the tissues of the arterial wall instead of the occlusion, thereby creating a false lumen and possibly perforating the artery. If blood escapes the artery and accumulates in the pericardial space, it will compress the heart, requiring emergency intervention to avert heart failure and death.
- One guidance system which has been used in conjunction with coronary catheterization is biplane fluoroscopy, wherein the interventionist observes two flat real-time x-ray images acquired from different angles. Biplane fluoroscopy, however, is unreliable, costly, and slow. Delay is unacceptable, for it contributes to trauma and stress and creates opportunities for complications and failures of technique.
- Recently, promising optical systems have been disclosed for imaging an occlusion through a catheter placed in the artery. One such system is Optical Coherence Tomography (OCT). In OCT, a beam of light carried by an optical fiber illuminates the artery interior. In a radar-like manner, light reflected back into the fiber from features inside the artery is correlated with the emitted light to capture the depth as well as the angular separation of those features. The features are displayed graphically in two or three dimensions through the use of a suitably programmed computer.
- The beam in OCT is swept by mechanical rotation or movement of optical components in the catheter, or by optical switching devices which select one of several fibers through which to perform measurements. The rotation is encoded, or the switching pattern recorded, for reconstructing angular information about the artery interior. For example, a beam splitter may be placed between the light source and the catheter fiber to produce a reference beam which is directed to a reflector at a known distance. The catheter beam and the reference beam are recombined as they return. When the paths traveled by the two beams are of equal optical length, interference fringes are observable in the combined beam. Since the lengths of the reference path and the catheter fiber are known, the distance from the fiber end to a particular reflective feature within the artery can be inferred. In OCT and related methods, signals may also be impressed upon the light beam to facilitate the measurement of distance or the detection of motion of objects relative to the fiber end. By means of OCT or other similar optical methods, imaging capability can be incorporated into an intravascular catheter or guidewire.
- However, while superior imagery alone is of diagnostic interest, effective intervention for severe occlusive arterial disease is what is truly desired. Even with improved guidance, there persists a long felt need for working elements which are capable of opening a path through or around an arterial occlusion at low risk of perforating the artery. What is needed is an intravascular catheter system for the effective treatment of the severely occluded artery and, in particular, the totally occluded artery. What is especially needed is a therapeutic working element which allows the physician to mechanically fracture an occlusion or to separate the occlusion from the intimal surface, but which is operable in a manner unlikely to perforate the adventitia.
- It is an object of this invention to provide a blunt end assembly for fracturing an occlusion within a blood vessel.
- It is an additional object of this invention to provide such an assembly wherein the assembly includes a catheter having a distal end and a proximal end and wherein a working end member fits in an interchangeable manner to the distal end of the catheter and wherein the working end comprises a blunt end member in accordance with the invention.
- It is an additional object of this invention to provide such an assembly wherein the blunt end member has a first closed position and a second open position and may be repeatedly opened and closed for fracturing the occlusion within the native lumen of the blood vessel.
- In accordance with the above objects and those that will be mentioned and will become apparent below, the blunt end member assembly in accordance with this invention comprises:
- a blunt end member connectable to the distal end of the catheter, the blunt end member sized and shaped for fitting within the blood vessel and for fracturing the occlusion, the blunt end member having a first position for allowing the blunt end member to be located at the occlusion and a second position for fracturing the occlusion; and
- an actuation member for moving the blunt end member between the first and second positions,
- whereby the blunt end member is connectable to the distal end of the catheter and the blunt end member is deliverable to the occlusion in the first position and is actuable to a second position for fracturing the occlusion.
- In one exemplary embodiment of the invention, an over-the-wire intravascular catheter is provided comprising a blunt end member disposed at the distal end thereof and a securing balloon disposed about the distal end zone of the catheter proximal to the blunt end member. The catheter and blunt end member are sized and shaped so as to allow the blunt end member to be advanced into contact with an occlusion in an artery. The balloon is disposed on the outer surface of the distal end zone of the catheter and is inflatable to secure the distal end of the catheter within the artery and thus to maintain engagement of the blunt end member with the occlusion. A balloon inflation lumen is provided in the catheter.
- The blunt end member comprises four jaw sections flexibly attached to the distal end of the catheter and arranged symmetrically about the longitudinal axis thereof. The catheter comprises a retractable actuation shad having a ball-shaped ferrule fixed to the distal end thereof between the jaw sections. To accommodate a guidewire, the actuation shad includes a lumen and the ferrule includes a center opening. The jaw sections have a first, closed position in which the catheter may be advanced to engage the jaws with the occlusion. When the actuation shaft, is retracted, the ferrule impinges upon the inner surfaces of the jaw sections, urging them apart toward a second, open position to fracture the occlusion.
- It is an advantage of this exemplary embodiment of the invention that fracturing force is stably applicable to a severe or total arterial occlusion. It is a further advantage of this exemplary embodiment that a mechanical working element is stably operable upon a severe or total arterial occlusion in a manner unlikely to perforate the adventitia.
- In another exemplary embodiment of the invention, the jaw sections are spade-shaped. In the first, closed position, the jaw sections form a channel substantially confining the guidewire to the longitudinal axis of the blunt end member. It is an advantage of this exemplary embodiment that when the jaw sections are in the first, closed position, a guidewire may be advanced into a portion of the occlusion bounded by the points of contact with the distal ends of the jaw sections.
- In another exemplary embodiment of the invention, the ferrule has a frusto-conical profile.
- In another exemplary embodiment of the invention, each jaw section includes a rectangular distal end.
- In another exemplary embodiment of the invention, the actuation member includes an actuation cable disposed in the catheter. The proximal end of the cable is manipulable from the proximal end of the catheter and the distal end of the cable is attached to the ferrule. It is an advantage of this exemplary embodiment of the invention that the cable increases the tension capacity of the actuation member during retraction of the ferrule.
- In another exemplary embodiment of the invention, the jaw sections are fabricated from an alloy comprising Nickel and Titanium. It is an advantage of this exemplary embodiment of the invention that the superelastic properties of the alloy facilitate spreading of the jaw sections when the ferrule is retracted.
- In another exemplary embodiment of the invention, a part of the lumen of the actuating member includes a friction reducing coating. It is an advantage of this exemplary embodiment of the invention that the catheter and blunt end slide easily over the guidewire.
- In another exemplary embodiment of the invention, the mating surface defined by the impingement of the actuation member upon the blunt end member includes a friction reducing coating. It is an advantage of this exemplary embodiment of the invention that the actuation member encounters minimal frictional resistance while urging the jaw sections apart.
- In another exemplary embodiment of the invention, the entire blunt end member is fabricated from a single piece of material. It is an advantage of this exemplary embodiment of the invention that fabrication of the blunt end member does not require attachment or assembly of multiple parts.
- In another exemplary embodiment of the invention, the blunt end member includes a rigid tubular reinforcing member slidably disposed about the actuation shaft inside the distal end zone of the catheter. A tubular support member is disposed on the outer surface of the distal end of the catheter. The distal end of the support member includes a spring member deformably supporting a plurality of jaw sections. The support member is crimped onto the distal end zone of the catheter, securing the catheter onto the reinforcing member. It is an advantage of this exemplary embodiment of the invention that a simple yet secure attachment is formed between the catheter and the blunt end member.
- For a further understanding of the objects and advantages of the present invention, reference should be had to the following detailed description, taken in conjunction with the accompanying drawings, in which like parts are given like reference numerals and wherein:
- FIG. 1 illustrates an exemplary embodiment of the blunt end member for fracturing a total occlusion in accordance with this invention shown in partial cross section.
- FIG. 2 is a partial cross sectional view of the catheter having the blunt end member of FIG. 1 in the process of fracturing the total occlusion.
- FIG. 3 is an enlarged side view of the blunt end member having a first closed position and a second open position.
- FIG. 4 is an end view of the blunt end member of FIG. 3 in the first or closed position.
- FIG. 5 is a cross sectional plane view of the blunt end member of FIG. 1 shown in cross sectional view.
- FIG. 6 is a cross sectional view of the blunt end member of FIG. 1 shown in the second open position.
- FIG. 7 is a cross sectional plane view of another exemplary embodiment of the blunt end member in accordance with this invention.
- FIG. 8 is a cross sectional view of the blunt end member of FIG. 7 shown in the second open position.
- FIG. 9 is an end view of the blunt end member of FIG. 8.
- FIG. 10 is an enlarged end view of the blunt end member of FIG. 7 shown in the second or open position.
- The invention will be described particularly with reference to a coronary bypass arterial condition. As illustrated in FIGS. 1 and 2, the blunt end member, in accordance with this invention, is shown adjacent to a total occlusion where a bypass is in the process of failing. The bypass has developed diffuse stenosis as shown in FIGS. 1 and 2. Consistent with the above description, it is quite likely that where stenosis has developed sufficiently to block an arterial blood vessel, after a bypass is performed. stenosis in the bypass will also accumulate. Even, to the point that the bypass may also be blocked or become totally occluded. Using the blunt end member, in accordance with this invention, the original, native blood vessel is reopened allowing the bypass to fade as the primary source of blood flow.
- It will of course be appreciated that the drawings are illustrative only, and that the invention made be used in any situation where the blood vessel, such as a coronary artery has been occluded, by stenosis or other arterial disease. The principal feature of the invention is to fracture the stenosis occluding blood flow and allow the native artery to resume the primary responsibility for blood flow.
- With particular reference to FIG. 1, there is shown the blunt end member assembly in accordance with this invention, generally designated by the numeral20. The
assembly 20 includes a blunt end member, generally indicated by the numeral 22, and acatheter 24. An actuation member indicated by doted lines 26 moves the blunt end member from a first closed position as illustrated in FIG. 1 to an second open position as illustrated in FIG. 2. - The catheter is positioned using a
guide wire 28 as best shown in FIG. 2, so that the extreme distal end of the blunt end member is adjacent to the total occlusion, as shown in FIGS. 1 and 2. Once positioned, the catheter which includes, in a exemplary embodiment, a member for stabilizing theassembly 20 in the blood, namely, aballoon member 30. Theballoon member 30 is inflated as shown in FIG. 2, so that the catheter remains in place during actuation of theblunt end member 22. - With particular reference to FIGS. 3 through 6, there is shown an exemplary first embodiment of the
blunt end member 22. Theblunt end member 22 has a proximal end 40 attached to the distal end of thecatheter 24. The method of attachment is conventional within the skill and knowledge of the prior art and is not explained herein in detail. - The blunt end member includes a set of sectional members defining
jaw sections 42. Thejaw sections 42 are located at the distal end of the blunt end member and are spaced equal distance of thelongitudinal center line 44. Thus, as will be appreciated herein after, thejaw sections 42 open to a second position shown particularly in FIGS. 3 and 6, and close to a first position as shown in FIGS. 3, 4, and 5. As will be explained below, an actuation member is required to move thejaw sections 42 from its first closed position to its second open position. - The
jaw sections 42 are generally spade shaped and are separate from one another as illustrated. This allows the jaw sections to meet flush against the arterial wall and the occlusion for optimizing fracturing of the occlusion. Thejaw sections 42 are spaced apart as shown in FIG. 4. - With respect to FIGS. 5 and 6, there is shown an assembly view of the
blunt end member 22 in accordance with the invention as illustrated in FIG. 4. FIG. 5 is a cross sectional view along line 5-5 of FIG. 4 and looking in the direction of the arrows. Theblunt end member 22 includes a reverseconical urging member 50 and a spaced apartsupport member 52. Themembers catheter 24. - Each of the
members longitudinal center line 44. Theopenings guide wire tube 54 is able to slide toward and away from the proximal end of thecatheter 24. - Attached to the
guide wire tube 54 is aferrule 56. Theferrule 56 also has a center opening aligned with the center openings of the members of 50 and 52. However, the center opening of theferrule 56 has a smaller diameter to match theguide wire 28 and not theguide wire tube 54. Thus, theferrule 56 is designed to accommodate only theguide wire 28 and not theguide wire tube 54. - The
guide wire 28 is shown inserted in the center opening of theferrule 56. It will also be appreciated that thejaw sections 42 are spaced apart a sufficient distance along thelongitudinal center line 44 so that the guide wire is guided thereby. As clearly shown in FIG. 5, thejaw sections 42, when closed, form ainternal guide 58 for sliding the guide wire toward and away from the distal end of thecatheter 24. - The
ferrule 56 may be made from a variety of materials including stainless steel, nickel titanium or other shape memory alloys and various engineering plastics. Additionally, other polymers or metal materials, which are bio-compatible and have the mechanical characteristics necessary to perform the functions herein are equally suitable. - The ferrule defines a frusto-conical shape, while the urging
member 50 forms a reverse compatible shape for sliding against the frusto conical shape of theferrule 56. The surfaces where each of theferrule 56 and the urgingmember 50 contact, define a mating surface. The materials selected for each of theferrule 56 and urgingmember 50 are compatible for such mating sliding contact. - In response to actuation, the
ferrule 56 is pulled toward the proximal end of thecatheter 24 causing theferrule 56 to slide against the urgingmember 50, the mating surfaces of each sliding across one another. As the ferrule is pulled towards the proximal end of the catheter, an increasing force is urged against thejaw sections 42 for spreading apart saidjaw sections 42. Upon full activation of the actuation member the jaws are fully open, as shown in FIG. 6. - In an exemplary embodiment of the invention, the blunt
end jaw members 42 must be made of material having sufficient strength to withstand the mechanical forces necessary to fracture the occlusion shown in FIGS. 1 and 2. In a preferred exemplary embodiment, the jaw sections are made from nickel titanium which has proven bio-compatible as well as having sufficient strength for the function intended herein. - The
guide wire tube 54 is bonded to the ferrule as shown in FIGS. 5 and 6. The bonding may be similar to the bonding of the catheter and theblunt end member 22. Additionally, bonding may be done by use of adhesives such as loc-tite™, soldering, or chemical or physical bonding, of a suitable kind. Theguide wire tube 54 being thus, permanently connected to the ferrule in a bond which is strong enough to withstand the urging forces exerted against the occlusion. The interior opening of themembers guide wire tube 54 as thejaw sections 42 are opened and closed in repeated use. It may be advantages to coat the interior opening of themembers guide wire 54, with Teflon or similar polymers so that the friction from the movement of sliding through the internal opening is greatly reduced. A reduction in friction will, of course, result in more force being applied by theferrule 56 against the urgingmember 50 to maximize the amount of fracturing power generated by theblunt end member 42. - Conventionally, the
guide wire tube 54 is a braided strand, and thus can be quite abrasive to the internal opening of the members of 50 and 52. Thus, the matter of applying a coating may be increasingly important to reduce the friction in the sliding movement. Additionally, it is preferable that the mating surfaces of the urgingmember 50 and theferrule 56 also be as smooth as possible and chosen from compatible materials to minimize the amount of friction developed as the mating surfaces slide against one another in an effort to fracture the occlusion of FIGS. 1 and 2. In an exemplary embodiment the ferrule and urging members are both made from nickel titanium. In another embodiment, the urgingmember 50 is made from stainless steel and theferrule 56 is made from nickel titanium. Again, the mating surfaces of theferrule 56 and urgingmember 50 are made as smooth as possible to minimize the friction there between. - As will be appreciated, the
support member 52 provides support both internal and external to theassembly 20. Thesupport member 52 remains fixedly attached to the distal end of thecatheter 24 and provides an internal opening for the sliding movement of theguide wire tube 54. Additionally, as will be appreciated in FIGS. 5 and 6, thejaw sections 42 have a proximal end zone 60 which surrounds both the urgingmember 50 and thesupport member 52. The proximal end zone of thejaw sections 42 secures themembers assembly 20. As shown in FIG. 6 the support member is notched atshoulder 62 to provide a secure connection fit with thejaw sections 42. - It will, of course, be appreciated that the entire assembly, including
members jaw sections 42, may be made from a single piece of nickel titanium (NiTi) for a unified assembly. In another exemplary embodiment in accordance with a unified assembly, the jaw sections would be notched with an opening at elbow 64, as shown in FIG. 6. This would allow space for deformation of the jaw sections along an axis predetermined by the angle and length of the opening. - With respect to FIGS. 7 through 10, there is shown a second embodiment of the blunt end member in accordance with this invention, generally designated by the numeral100. The
blunt end member 100 includes jaw sections, as illustrated in FIGS. 8 and 10, designated by the numeral 102. Theblunt end member 100 includes aspring member 104 and asupport member 106. A reinforcingmember 108 is positioned between thecatheter tube 24 and theguide wire tube 54 in the guide wire lumen of thecatheter tube 24. Attached to theguide wire tube 54 is aferrule 56 as discussed previously with regard to the earlier described embodiment. - Similar to the reverse
conical urging member 50, thespring member 104 has a mating surface for mating with theferrule 56, as clearly shown in FIG. 8. Upon actuation, theferrule 56 is pulled toward the proximal end of thecatheter 24 and the mating surfaces engage and separate thejaw sections 102, as shown in FIGS. 8 and 10. Upon releasing the actuation member, thespring member 104 urges thejaw sections 102, back to their original and first closed positioned, as clearly shown in FIGS. 7 and 9. Thespring member 104 serves to connect thejaw sections 102 and the rest of theblunt end member 100, and specifically thesupport member 106. Thesupport member 106 is crimped at itsproximal end 110. The reinforcingmember 108 is positioned so that the crimp in thesupport member 106 sandwiches the distal end of thecatheter tube 24. It will be appreciated that the hoop strength provided by the reinforcingmember 108 enables a secure attachment of the support member to the distal end of thecatheter tube 24. It will be further appreciated that the crimp in the support member, plus the added hoop strength provided by the reinforcingmember 108, provide a secure connection for the entireblunt end member 100. - Typically the blunt end member is supported by the connections at the joining of the
spring 104, thejaw sections 102, andsupport member 106. These joints can be done in a variety of ways. For example, it is preferable to bond the members with an epoxy, should they be made of a polymer or to use welding, soldering, or brazing, if the members are made from metal. - In a preferred exemplary embodiment, the
spring 104 is made from nickel titanium as are thesupport member 106 andjaw sections 102. In other embodiments, it is contemplated within the scope of this invention to make the support and spring members, 106 and 104, respectively, from stainless steel. Additionally, the reinforcingmember 108 may be made alternately from nickel titanium or stainless steel. It is also contemplated that various other types of materials are suitable for manufacturing of theblunt end member 100 as described above. - The operation of the second exemplary embodiment will now be described in detail with reference to FIGS. 7 through 10. As shown in FIG. 7, the
blunt end member 100 is in its normal or first closed position, as clearly illustrated in FIG. 7. As is typical in DCA operations, theguide wire 28 is fed through the lumen of the blood vessels of a patient. Upon reaching the selected location, such as that illustrated in FIGS. 1 and 2, the guide wire will meet an occlusion. Theblunt end member 100 withferrule 56 will be positioned, as described earlier, directly adjacent to the occlusion. Although not shown, it will be appreciated that theballoon 30 of FIGS. 1 and 2 may also be adapted for use with the second exemplary embodiment shown in FIGS. 7 through 10. - After stabilization of the
catheter 24 in the lumen of the blood vessel, theblunt end member 100 is activated by pulling on an actuation member such that the mating surfaces of thespring 104 and theferrule 56 are brought into contact with one another. Theferrule 56 moves thejaw sections 102 away from thelongitudinal center line 44 of the catheter as described earlier with reference to FIGS. 1 through 6. This operation is repeated until fracturing occurs, as clearly shown in FIG. 2. Once fracturing occurs, and theguide wire 28 can be fed through the natural lumen of the blood vessel, the catheter may be removed and another working end may be brought to bear upon the occlusion. Such working end may include an angioplasty device, atherectomy catheter device, or a stent or other known medical methods, for removing the occlusion once theguide wire 28 is across the occlusion. - While the foregoing detailed description has described several embodiments of the method in accordance with this invention, it is to be understood that the above description is illustrative only and not limiting of the disclosed invention. Particularly, the invention need not be limited to a ferrule having a frusto-conical shape. It will be appreciated that a spherical ferrule could also be used within the spirit and scope of this invention. It will also be appreciated that the various elements which make up the blunt end member may be made from stainless steel, or some engineering plastic, including a suitable polymer. Additionally, while the invention has been described with regard to a bypass type of operation, it will be appreciated that other medical procedures wherein a occlusion blocks a blood vessel, or substantially blocks a blood vessel, or at least prevents a guide wire from easy going across the occlusion, are suitable for use with the invention described herein. Thus, the invention is to be limited only by the claims as set forth below.
Claims (27)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/032,773 US6398798B2 (en) | 1998-02-28 | 1998-02-28 | Catheter system for treating a vascular occlusion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/032,773 US6398798B2 (en) | 1998-02-28 | 1998-02-28 | Catheter system for treating a vascular occlusion |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010020172A1 true US20010020172A1 (en) | 2001-09-06 |
US6398798B2 US6398798B2 (en) | 2002-06-04 |
Family
ID=21866735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/032,773 Expired - Lifetime US6398798B2 (en) | 1998-02-28 | 1998-02-28 | Catheter system for treating a vascular occlusion |
Country Status (1)
Country | Link |
---|---|
US (1) | US6398798B2 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055371A1 (en) * | 1998-01-30 | 2003-03-20 | Percardia, Inc. | Left ventricular conduits to coronary arteries and methods for coronary bypass |
US20030137008A1 (en) * | 2000-03-28 | 2003-07-24 | Hidetoshi Nozaki | Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same |
US20040133969A1 (en) * | 2003-01-10 | 2004-07-15 | Tyler Pipe Company, A Division Of Ransom Industries, Lp | Closet carrier system and method of assembly |
US20060112956A1 (en) * | 2002-11-06 | 2006-06-01 | Michel Serpelloni | Use of branched malto-dextrins as granulation binders |
WO2008113985A1 (en) * | 2007-03-20 | 2008-09-25 | Smiths Group Plc | Tracheostomy devices |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US20110144671A1 (en) * | 2009-06-18 | 2011-06-16 | Cardiovascular Systems, Inc. | Atherectomy device, system and method having a bi-directional distal expandable ablation element |
US20110166591A1 (en) * | 2006-02-13 | 2011-07-07 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6217549B1 (en) | 1997-02-28 | 2001-04-17 | Lumend, Inc. | Methods and apparatus for treating vascular occlusions |
US6508825B1 (en) * | 1997-02-28 | 2003-01-21 | Lumend, Inc. | Apparatus for treating vascular occlusions |
US20050171478A1 (en) * | 1998-01-13 | 2005-08-04 | Selmon Matthew R. | Catheter system for crossing total occlusions in vasculature |
US6949114B2 (en) * | 1998-11-06 | 2005-09-27 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
NL1011063C2 (en) * | 1999-01-19 | 2000-07-24 | Robertus Johannes Theodorus Jo | Device for stripping veins. |
US20030125757A1 (en) * | 2000-12-20 | 2003-07-03 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US20030120295A1 (en) * | 2000-12-20 | 2003-06-26 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US7887556B2 (en) * | 2000-12-20 | 2011-02-15 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US6638233B2 (en) | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
ATE499054T1 (en) | 2000-12-20 | 2011-03-15 | Fox Hollow Technologies Inc | REDUCTION CATHETER |
US20050154407A1 (en) * | 2000-12-20 | 2005-07-14 | Fox Hollow Technologies, Inc. | Method of evaluating drug efficacy for treating atherosclerosis |
US20040167554A1 (en) * | 2000-12-20 | 2004-08-26 | Fox Hollow Technologies, Inc. | Methods and devices for reentering a true lumen from a subintimal space |
US20100121360A9 (en) * | 2000-12-20 | 2010-05-13 | Fox Hollow Technologies, Inc | Testing a patient population having a cardiovascular condition for drug efficacy |
US20060235366A1 (en) * | 2000-12-20 | 2006-10-19 | Fox Hollow Technologies, Inc. | Method of evaluating a treatment for vascular disease |
US7927784B2 (en) * | 2000-12-20 | 2011-04-19 | Ev3 | Vascular lumen debulking catheters and methods |
US7699790B2 (en) * | 2000-12-20 | 2010-04-20 | Ev3, Inc. | Debulking catheters and methods |
US20020143358A1 (en) * | 2001-02-13 | 2002-10-03 | Domingo Nicanor A. | Method and apparatus for micro-dissection of vascular occlusions |
US6951570B2 (en) * | 2001-07-02 | 2005-10-04 | Rubicon Medical, Inc. | Methods, systems, and devices for deploying a filter from a filter device |
US6962598B2 (en) * | 2001-07-02 | 2005-11-08 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection |
US6623489B2 (en) * | 2001-07-11 | 2003-09-23 | Daniel Cherfas | Device for destroying formations in a body |
US7300442B2 (en) * | 2001-07-11 | 2007-11-27 | Daniel Cherfas | Method of destroying formations in a body |
US8061006B2 (en) * | 2001-07-26 | 2011-11-22 | Powderject Research Limited | Particle cassette, method and kit therefor |
US20030023261A1 (en) | 2001-07-30 | 2003-01-30 | Scimed Life Systems Inc. | Chronic total occlusion device with variable stiffness shaft |
US6632231B2 (en) * | 2001-08-23 | 2003-10-14 | Scimed Life Systems, Inc. | Segmented balloon catheter blade |
US7734332B2 (en) * | 2002-10-18 | 2010-06-08 | Ariomedica Ltd. | Atherectomy system with imaging guidewire |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
US7632288B2 (en) | 2003-05-12 | 2009-12-15 | Boston Scientific Scimed, Inc. | Cutting balloon catheter with improved pushability |
US7758604B2 (en) | 2003-05-29 | 2010-07-20 | Boston Scientific Scimed, Inc. | Cutting balloon catheter with improved balloon configuration |
JP4653104B2 (en) * | 2003-06-10 | 2011-03-16 | ルーメンド インコーポレイテッド | Catheter apparatus and method for opening a vascular occlusion |
US7780626B2 (en) * | 2003-08-08 | 2010-08-24 | Boston Scientific Scimed, Inc. | Catheter shaft for regulation of inflation and deflation |
US7887557B2 (en) * | 2003-08-14 | 2011-02-15 | Boston Scientific Scimed, Inc. | Catheter having a cutting balloon including multiple cavities or multiple channels |
US7211098B2 (en) * | 2004-03-23 | 2007-05-01 | Linvatec Corporation | Dilator for bone tunnels |
US7754047B2 (en) | 2004-04-08 | 2010-07-13 | Boston Scientific Scimed, Inc. | Cutting balloon catheter and method for blade mounting |
US7566319B2 (en) | 2004-04-21 | 2009-07-28 | Boston Scientific Scimed, Inc. | Traction balloon |
US8043259B2 (en) * | 2004-05-24 | 2011-10-25 | Boston Scientific Scimed, Inc. | Medical device systems |
US7976557B2 (en) | 2004-06-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
US7597703B2 (en) * | 2004-09-07 | 2009-10-06 | Medtronic Vascular, Inc. | Mechanically expandable occluder |
US8038691B2 (en) | 2004-11-12 | 2011-10-18 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having flexible atherotomes |
US8066726B2 (en) * | 2004-11-23 | 2011-11-29 | Boston Scientific Scimed, Inc. | Serpentine cutting blade for cutting balloon |
US20060184191A1 (en) | 2005-02-11 | 2006-08-17 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having increased flexibility regions |
WO2006105244A2 (en) * | 2005-03-30 | 2006-10-05 | Lumend, Inc. | Catheter systems for crossing total occlusions in vasculature |
US7794413B2 (en) * | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
US20060247674A1 (en) * | 2005-04-29 | 2006-11-02 | Roman Ricardo D | String cutting balloon |
EP1885259B1 (en) | 2005-05-11 | 2016-08-17 | Mayo Foundation For Medical Education And Research | Apparatus for internal surgical procedures |
US20070038173A1 (en) * | 2005-07-27 | 2007-02-15 | Fox Hollow Technologies, Inc. | Methods affecting markers in patients having vascular disease |
US20070032808A1 (en) * | 2005-08-03 | 2007-02-08 | Azam Anwar | System and method for addressing total occlusion in a vascular environment |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8083727B2 (en) * | 2005-09-12 | 2011-12-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
EP1924315B1 (en) | 2005-09-12 | 2019-12-04 | Bridgepoint Medical, Inc. | Endovascular devices |
US11020141B2 (en) | 2005-09-12 | 2021-06-01 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US7938819B2 (en) | 2005-09-12 | 2011-05-10 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
US9060802B2 (en) | 2006-11-21 | 2015-06-23 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US11298511B2 (en) | 2006-11-21 | 2022-04-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US10888354B2 (en) | 2006-11-21 | 2021-01-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
EP2131913B1 (en) * | 2007-03-29 | 2022-01-05 | Boston Scientific Medical Device Limited | Lumen reentry devices |
EP3659664A1 (en) | 2007-10-22 | 2020-06-03 | Bridgepoint Medical, Inc. | Devices for crossing chronic total occlusions |
US8337425B2 (en) | 2008-02-05 | 2012-12-25 | Bridgepoint Medical, Inc. | Endovascular device with a tissue piercing distal probe and associated methods |
EP2259830B1 (en) | 2008-02-05 | 2017-08-16 | Bridgepoint Medical, Inc. | Crossing occlusions in blood vessels |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
EP2291128B1 (en) | 2008-04-28 | 2016-08-31 | Bridgepoint Medical, Inc. | Apparatus for crossing occlusions in blood vessels |
US8162964B2 (en) | 2008-06-05 | 2012-04-24 | Cardiovascular Systems, Inc. | Split flexible tube biasing and directional atherectomy device and method |
KR101645754B1 (en) | 2008-10-13 | 2016-08-04 | 코비디엔 엘피 | Devices and methods for manipulating a catheter shaft |
CN102625673B (en) | 2009-04-29 | 2014-12-24 | 泰科保健集团有限合伙公司 | Methods and devices for cutting and abrading tissue |
AU2010248909B2 (en) | 2009-05-14 | 2013-03-21 | Covidien Lp | Easily cleaned atherectomy catheters and methods of use |
WO2011025855A2 (en) | 2009-08-28 | 2011-03-03 | Si Therapies Ltd. | Inverted balloon neck on catheter |
AU2010326063B2 (en) | 2009-12-02 | 2013-07-04 | Covidien Lp | Methods and devices for cutting tissue |
JP5511107B2 (en) | 2009-12-11 | 2014-06-04 | コヴィディエン リミテッド パートナーシップ | Substance removal device and method with improved substance capture efficiency |
US9119662B2 (en) | 2010-06-14 | 2015-09-01 | Covidien Lp | Material removal device and method of use |
CA2815186C (en) | 2010-10-28 | 2015-12-29 | Covidien Lp | Material removal device and method of use |
AU2011326420B2 (en) | 2010-11-11 | 2014-11-27 | Covidien Lp | Flexible debulking catheters with imaging and methods of use and manufacture |
US8821478B2 (en) | 2011-03-04 | 2014-09-02 | Boston Scientific Scimed, Inc. | Catheter with variable stiffness |
US8992717B2 (en) | 2011-09-01 | 2015-03-31 | Covidien Lp | Catheter with helical drive shaft and methods of manufacture |
AU2012312666B2 (en) | 2011-09-19 | 2016-09-15 | Boston Scientific Scimed, Inc. | Subintimal re-entry catheter and retrograde recanalization |
CN103974676B (en) | 2011-12-09 | 2016-12-07 | 波士顿科学西美德公司 | Utilize under the inner membrance of biological absorbable support the most logical |
US9486239B2 (en) | 2012-05-24 | 2016-11-08 | Boston Scientific Scimed, Inc. | Subintimal re-entry device |
WO2014012008A1 (en) | 2012-07-13 | 2014-01-16 | Boston Scientific Scimed, Inc. | Subintimal reentry system |
US9456842B2 (en) | 2012-07-13 | 2016-10-04 | Boston Scientific Scimed, Inc. | Wire-guided recanalization system |
US9579157B2 (en) | 2012-09-13 | 2017-02-28 | Covidien Lp | Cleaning device for medical instrument and method of use |
US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
WO2014159549A2 (en) | 2013-03-14 | 2014-10-02 | Boston Scientific Scimed, Inc. | Systems, apparatus and methods for treating blood vessels |
WO2014150424A1 (en) | 2013-03-14 | 2014-09-25 | Boston Scientific Scimed, Inc. | Subintimal re-entry catheter with shape controlled balloon |
US10098650B2 (en) | 2014-06-09 | 2018-10-16 | Boston Scientific Scimed, Inc. | Systems and methods for treating atherosclerotic plaque |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
US11389628B2 (en) | 2015-03-19 | 2022-07-19 | Boston Scientific Scimed, Inc. | Subintimal re-entry balloon catheter |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
CN114948106A (en) | 2017-05-03 | 2022-08-30 | 美敦力瓦斯科尔勒公司 | Tissue removal catheter with guidewire isolation bushing |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
EP3880096A1 (en) | 2018-11-16 | 2021-09-22 | Medtronic Vascular Inc. | Tissue-removing catheter |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US832201A (en) | 1904-12-12 | 1906-10-02 | Samuel L Kistler | Dilator. |
US1127948A (en) | 1914-12-31 | 1915-02-09 | Reinhold H Wappler | Cystoscope. |
US1267066A (en) | 1917-10-20 | 1918-05-21 | Theodore J Flack | Adjustable rectal dilator. |
US2621651A (en) | 1949-06-02 | 1952-12-16 | American Cystoscope Makers Inc | Instrument for dilating and examining the esophagus |
FR1585065A (en) | 1968-06-24 | 1970-01-09 | ||
DE1939523B1 (en) | 1969-08-02 | 1971-02-04 | Niess Ingeborg Elektromedizin | Suction electrode device for electrical medical devices |
US3667474A (en) | 1970-01-05 | 1972-06-06 | Konstantin Vasilievich Lapkin | Dilator for performing mitral and tricuspidal commissurotomy per atrium cordis |
JPS5176120A (en) | 1974-12-27 | 1976-07-01 | Showa Aluminium Co Ltd | |
US5133727A (en) | 1990-05-10 | 1992-07-28 | Symbiosis Corporation | Radial jaw biopsy forceps |
DE2945237A1 (en) | 1979-11-09 | 1981-05-14 | Stavros Prof. Dr.med. 5100 Aachen Lymberopoulos | Urinary passage stone-removal grip - has dish-shaped head contracted to catheter tube dia. by pulling control member |
US4355643A (en) | 1980-03-05 | 1982-10-26 | University Of Iowa Research Foundation | Vacuum cup doppler flow transducer and method for using same |
USRE32158E (en) | 1980-07-30 | 1986-05-27 | Arthroscope | |
US4630609A (en) | 1981-05-14 | 1986-12-23 | Thomas J. Fogarty | Dilatation catheter method and apparatus |
US4848336A (en) | 1981-12-11 | 1989-07-18 | Fox Kenneth R | Apparatus for laser treatment of body lumens |
US4470407A (en) | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
US4585000A (en) | 1983-09-28 | 1986-04-29 | Cordis Corporation | Expandable device for treating intravascular stenosis |
US4572186A (en) | 1983-12-07 | 1986-02-25 | Cordis Corporation | Vessel dilation |
US4541433A (en) | 1984-06-01 | 1985-09-17 | Medtronic, Inc. | Cardiac output monitor |
US5114414A (en) | 1984-09-18 | 1992-05-19 | Medtronic, Inc. | Low profile steerable catheter |
DE3443337A1 (en) | 1984-11-28 | 1986-05-28 | Richard Wolf Gmbh, 7134 Knittlingen | INSTRUMENT FOR THE EXAMINATION AND TREATMENT OF BODY CHANNELS |
US4669467A (en) | 1985-03-22 | 1987-06-02 | Massachusetts Institute Of Technology | Mode mixer for a laser catheter |
US5102390A (en) | 1985-05-02 | 1992-04-07 | C. R. Bard, Inc. | Microdilatation probe and system for performing angioplasty in highly stenosed blood vessels |
US4648402A (en) | 1985-10-03 | 1987-03-10 | Santos Manuel V | Blood vessel dilating surgical instrument |
CH668192A5 (en) | 1985-11-29 | 1988-12-15 | Schneider Medintag Ag | CATHETER FOR TREATING NARROW BODIES, FOR EXAMPLE IN A BLOOD VESSEL. |
US4681110A (en) | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US4698057A (en) | 1986-06-09 | 1987-10-06 | Joishy Suresh K | Built in assembly for stabilizing and securing intravascular needle or catheter like device |
US4723549A (en) | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4794928A (en) | 1987-06-10 | 1989-01-03 | Kletschka Harold D | Angioplasty device and method of using the same |
DE3719250A1 (en) | 1987-06-10 | 1988-12-22 | Kellner Hans Joerg Dr Med | ENDOSCOPE |
US5001556A (en) | 1987-09-30 | 1991-03-19 | Olympus Optical Co., Ltd. | Endoscope apparatus for processing a picture image of an object based on a selected wavelength range |
US5156594A (en) | 1990-08-28 | 1992-10-20 | Scimed Life Systems, Inc. | Balloon catheter with distal guide wire lumen |
DE8904026U1 (en) | 1988-04-20 | 1989-05-24 | Schneider (Europe) Ag, Zuerich, Ch | |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US4886067A (en) | 1989-01-03 | 1989-12-12 | C. R. Bard, Inc. | Steerable guidewire with soft adjustable tip |
US5099850A (en) | 1989-01-17 | 1992-03-31 | Olympus Optical Co., Ltd. | Ultrasonic diagnostic apparatus |
US4919112B1 (en) | 1989-04-07 | 1993-12-28 | Low-cost semi-disposable endoscope | |
US5179961A (en) | 1989-04-13 | 1993-01-19 | Littleford Philip O | Catheter guiding and positioning method |
DE69024219T2 (en) | 1989-08-16 | 1996-11-07 | Raychem Corp | ARRANGEMENT FOR GRIPING OR CUTTING AN OBJECT |
US5019040A (en) | 1989-08-31 | 1991-05-28 | Koshin Sangyo Kabushiki Kaisha | Catheter |
US5034001A (en) | 1989-09-08 | 1991-07-23 | Advanced Cardiovascular Systems, Inc. | Method of repairing a damaged blood vessel with an expandable cage catheter |
US5180368A (en) | 1989-09-08 | 1993-01-19 | Advanced Cardiovascular Systems, Inc. | Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels |
US5263963A (en) | 1989-09-08 | 1993-11-23 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter for repairing a damaged blood vessel |
US5100425A (en) | 1989-09-14 | 1992-03-31 | Medintec R&D Limited Partnership | Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses |
US5092839A (en) | 1989-09-29 | 1992-03-03 | Kipperman Robert M | Coronary thrombectomy |
US5030201A (en) | 1989-11-24 | 1991-07-09 | Aubrey Palestrant | Expandable atherectomy catheter device |
US5089006A (en) | 1989-11-29 | 1992-02-18 | Stiles Frank B | Biological duct liner and installation catheter |
US5345927A (en) | 1990-03-02 | 1994-09-13 | Bonutti Peter M | Arthroscopic retractors |
US5197971A (en) | 1990-03-02 | 1993-03-30 | Bonutti Peter M | Arthroscopic retractor and method of using the same |
DE4018525C2 (en) | 1990-06-09 | 1994-05-05 | Kaltenbach Martin | Expandable area catheter |
DE9190089U1 (en) | 1990-06-11 | 1993-02-11 | Schneider (Usa) Inc., Plymouth, Minn., Us | |
DE9106499U1 (en) | 1990-08-09 | 1991-07-25 | Schneider (Europe) Ag, Zuerich, Ch | |
US5192290A (en) | 1990-08-29 | 1993-03-09 | Applied Medical Resources, Inc. | Embolectomy catheter |
WO1992008510A1 (en) | 1990-11-09 | 1992-05-29 | Boston Scientific Corporation | Guidewire for crossing occlusions in blood vessels |
AU660444B2 (en) | 1991-02-15 | 1995-06-29 | Ingemar H. Lundquist | Torquable catheter and method |
US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
WO1992019930A1 (en) | 1991-04-29 | 1992-11-12 | Massachusetts Institute Of Technology | Method and apparatus for optical imaging and measurement |
US5193546A (en) | 1991-05-15 | 1993-03-16 | Alexander Shaknovich | Coronary intravascular ultrasound imaging method and apparatus |
US5217484A (en) | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5766151A (en) | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5263959A (en) | 1991-10-21 | 1993-11-23 | Cathco, Inc. | Dottering auger catheter system and method |
US5423846A (en) | 1991-10-21 | 1995-06-13 | Cathco, Inc. | Dottering auger catheter system |
US5649950A (en) | 1992-01-22 | 1997-07-22 | C. R. Bard | System for the percutaneous transluminal front-end loading delivery and retrieval of a prosthetic occluder |
WO1993018818A1 (en) | 1992-03-18 | 1993-09-30 | The Spectranetics Corporation | Fiber optic catheter with twistable tip |
US5336252A (en) | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
AU682003B2 (en) | 1992-06-26 | 1997-09-18 | Schneider (Usa) Inc. | Catheter with expandable wire mesh tip |
GB9213978D0 (en) | 1992-07-01 | 1992-08-12 | Skidmore Robert | Medical devices |
US5351678A (en) | 1992-09-01 | 1994-10-04 | Citation Medical Corporation | Endoscope scope assembly for full hemisphere view |
US5282817A (en) | 1992-09-08 | 1994-02-01 | Hoogeboom Thomas J | Actuating handle for multipurpose surgical instrument |
WO1995022283A1 (en) | 1992-10-26 | 1995-08-24 | Ultrasonic Sensing & Monitoring Systems, Inc. | Catheter using optical fibers to transmit laser and ultrasonic energy |
US5350377A (en) | 1992-10-26 | 1994-09-27 | Ultrasonic Sensing & Monitoring Systems, Inc. | Medical catheter using optical fibers that transmit both laser energy and ultrasonic imaging signals |
US5540707A (en) | 1992-11-13 | 1996-07-30 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5490859A (en) | 1992-11-13 | 1996-02-13 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5501694A (en) | 1992-11-13 | 1996-03-26 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5383467A (en) | 1992-11-18 | 1995-01-24 | Spectrascience, Inc. | Guidewire catheter and apparatus for diagnostic imaging |
US5439000A (en) | 1992-11-18 | 1995-08-08 | Spectrascience, Inc. | Method of diagnosing tissue with guidewire |
US5304199A (en) | 1993-01-04 | 1994-04-19 | Gene E. Myers Enterprises, Inc. | Apparatus for arterial total occlusion plaque separation |
US5279565A (en) * | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5404886A (en) | 1993-05-14 | 1995-04-11 | Schneider (Usa) Inc. | Exchangeable guidewire |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
EP0643980B1 (en) | 1993-09-21 | 1998-12-30 | United States Surgical Corporation | Surgical instrument for expanding body tissue |
AU1399995A (en) | 1993-12-09 | 1995-06-27 | Devices For Vascular Intervention, Inc. | Composite drive shaft |
WO1995019143A1 (en) | 1994-01-14 | 1995-07-20 | Paul G. Yock And Robert J. Siegel, A Joint Venture | Ultrasonic ablation of stenoses and occlusions with imaging guidance |
US5443477A (en) | 1994-02-10 | 1995-08-22 | Stentco, Inc. | Apparatus and method for deployment of radially expandable stents by a mechanical linkage |
US5599306A (en) | 1994-04-01 | 1997-02-04 | Localmed, Inc. | Method and apparatus for providing external perfusion lumens on balloon catheters |
US5415636A (en) | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US5484412A (en) | 1994-04-19 | 1996-01-16 | Pierpont; Brien E. | Angioplasty method and means for performing angioplasty |
US5522819A (en) | 1994-05-12 | 1996-06-04 | Target Therapeutics, Inc. | Dual coil medical retrieval device |
US5499995C1 (en) | 1994-05-25 | 2002-03-12 | Paul S Teirstein | Body passageway closure apparatus and method of use |
US5573531A (en) | 1994-06-20 | 1996-11-12 | Gregory; Kenton W. | Fluid core laser angioscope |
DE4429117A1 (en) | 1994-08-17 | 1996-02-22 | Bess Medizintechnik Gmbh | Dilatation catheter for vessel or tissue restrictions |
US5626607A (en) | 1995-04-03 | 1997-05-06 | Heartport, Inc. | Clamp assembly and method of use |
US5556408A (en) | 1995-04-27 | 1996-09-17 | Interventional Technologies Inc. | Expandable and compressible atherectomy cutter |
US5713907A (en) | 1995-07-20 | 1998-02-03 | Endotex Interventional Systems, Inc. | Apparatus and method for dilating a lumen and for inserting an intraluminal graft |
US5688234A (en) | 1996-01-26 | 1997-11-18 | Cardiometrics Inc. | Apparatus and method for the treatment of thrombotic occlusions in vessels |
US5800450A (en) | 1996-10-03 | 1998-09-01 | Interventional Technologies Inc. | Neovascularization catheter |
US6010449A (en) * | 1997-02-28 | 2000-01-04 | Lumend, Inc. | Intravascular catheter system for treating a vascular occlusion |
US6015423A (en) | 1998-04-10 | 2000-01-18 | Andrese; Craig A. | Dilatation catheter tip for angioplasty procedures |
-
1998
- 1998-02-28 US US09/032,773 patent/US6398798B2/en not_active Expired - Lifetime
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055371A1 (en) * | 1998-01-30 | 2003-03-20 | Percardia, Inc. | Left ventricular conduits to coronary arteries and methods for coronary bypass |
US8597226B2 (en) | 1998-09-10 | 2013-12-03 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US8216174B2 (en) | 1998-09-10 | 2012-07-10 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7704222B2 (en) | 1998-09-10 | 2010-04-27 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US7736327B2 (en) | 1998-09-10 | 2010-06-15 | Jenavalve Technology, Inc. | Methods and conduits for flowing blood from a heart chamber to a blood vessel |
US20030137008A1 (en) * | 2000-03-28 | 2003-07-24 | Hidetoshi Nozaki | Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same |
US20060112956A1 (en) * | 2002-11-06 | 2006-06-01 | Michel Serpelloni | Use of branched malto-dextrins as granulation binders |
US20040133969A1 (en) * | 2003-01-10 | 2004-07-15 | Tyler Pipe Company, A Division Of Ransom Industries, Lp | Closet carrier system and method of assembly |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US20110166591A1 (en) * | 2006-02-13 | 2011-07-07 | Osamu Katoh | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
WO2008113985A1 (en) * | 2007-03-20 | 2008-09-25 | Smiths Group Plc | Tracheostomy devices |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US20110144671A1 (en) * | 2009-06-18 | 2011-06-16 | Cardiovascular Systems, Inc. | Atherectomy device, system and method having a bi-directional distal expandable ablation element |
US8795304B2 (en) | 2009-06-18 | 2014-08-05 | Cardiovascular Systems, Inc. | Atherectomy device, system and method having a bi-directional distal expandable ablation element |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
Also Published As
Publication number | Publication date |
---|---|
US6398798B2 (en) | 2002-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5968064A (en) | Catheter system for treating a vascular occlusion | |
US6398798B2 (en) | Catheter system for treating a vascular occlusion | |
US5741270A (en) | Manual actuator for a catheter system for treating a vascular occlusion | |
US6800085B2 (en) | Methods and apparatus for treating vascular occlusions | |
US6746462B1 (en) | Methods and apparatus for treating vascular occlusions | |
EP1112103B1 (en) | Apparatus for treating vascular occlusions | |
US6120516A (en) | Method for treating vascular occlusion | |
US6010449A (en) | Intravascular catheter system for treating a vascular occlusion | |
US10335174B2 (en) | System and method for re-entering a vessel lumen | |
JP4680386B2 (en) | Method and apparatus for traversing a vascular occlusion | |
JP3045306B2 (en) | Vascular catheter | |
US8932315B2 (en) | Systems and methods for percutaneous occlusion crossing | |
US6081738A (en) | Method and apparatus for the guided bypass of coronary occlusions | |
EP1251900B1 (en) | Angioplasty device | |
US20040230219A1 (en) | Anchoring, supporting and centering catheter system for treating chronic total occlusions | |
US20070265647A1 (en) | Atherectomy system having a variably exposed cutter | |
US20030208229A1 (en) | Embolic protection device having an expandable trap | |
EP1513462B1 (en) | Angioplasty device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LUMEND,INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SELMON ET AL.;REEL/FRAME:009432/0701 Effective date: 19980730 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: COMERICA BANK, CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:LUMEND, INC.;REEL/FRAME:014782/0652 Effective date: 20040614 |
|
AS | Assignment |
Owner name: CHL MEDICAL PARTNERS II, L.P., AS COLLATERAL AGENT Free format text: SECURITY INTEREST;ASSIGNOR:LUMEND, INC.;REEL/FRAME:014845/0191 Effective date: 20040624 |
|
AS | Assignment |
Owner name: LUMEND, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:COMERICA BANK;REEL/FRAME:016570/0392 Effective date: 20050509 |
|
AS | Assignment |
Owner name: LUMEND, INC., CALIFORNIA Free format text: REASSIGNMENT AND RELEASE OF SECURITY INTEREST;ASSIGNOR:COMERICA BANK;REEL/FRAME:016580/0055 Effective date: 20050509 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: LUMEND, INC., CALIFORNIA Free format text: TERMINATION OF PATENT SECURITY INTEREST;ASSIGNOR:CHL MEDICAL PARTNERS II, L.P., AS COLLATERAL AGENT FOR THE SECURED PARTIES;REEL/FRAME:017006/0472 Effective date: 20050919 |
|
AS | Assignment |
Owner name: LUMEND, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:COMERICA BANK;REEL/FRAME:020339/0297 Effective date: 20080107 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: CORDIS CORPORATION, CALIFORNIA Free format text: MERGER;ASSIGNOR:LUMEND, INC.;REEL/FRAME:033053/0980 Effective date: 20131210 |
|
AS | Assignment |
Owner name: CARDINAL HEALTH SWITZERLAND 515 GMBH, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;REEL/FRAME:042126/0259 Effective date: 20170329 |